These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10701699)

  • 21. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abacavir: absolute bioavailability, bioequivalence of three oral formulations, and effect of food.
    Chittick GE; Gillotin C; McDowell JA; Lou Y; Edwards KD; Prince WT; Stein DS
    Pharmacotherapy; 1999 Aug; 19(8):932-42. PubMed ID: 10453964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.
    Yuen GJ; Morris DM; Mydlow PK; Haidar S; Hall ST; Hussey EK
    J Clin Pharmacol; 1995 Dec; 35(12):1174-80. PubMed ID: 8750368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative bioavailability and safety profile of gefitinib administered as a tablet or as a dispersion preparation via drink or nasogastric tube: results of a randomized, open-label, three-period crossover study in healthy volunteers.
    Cantarini MV; McFarquhar T; Smith RP; Bailey C; Marshall AL
    Clin Ther; 2004 Oct; 26(10):1630-6. PubMed ID: 15598479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Wit FW; Lange JM; Danner SA; Foudraine NA; Kwakkelstein MO; Reiss P; Beijnen JH; Hoetelmans RM
    AIDS; 2000 May; 14(8):F77-82. PubMed ID: 10853971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
    Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
    Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study.
    Kasibhatta R; Naidu MU
    Drugs R D; 2007; 8(6):383-91. PubMed ID: 17963429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach.
    Dailly E; Raffi F; Perré P; Martin J; Deslandes G; Jolliet P
    HIV Med; 2009 Oct; 10(9):586-9. PubMed ID: 19486187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic profiling and bioequivalence assessment of two marketed brands of nevirapine tablets in healthy Indian volunteers.
    Narang VS; Lulla A; Malhotra G; Purandare S
    Arzneimittelforschung; 2005; 55(10):598-603. PubMed ID: 16294506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic study of the interaction between itraconazole and nevirapine.
    Jaruratanasirikul S; Sriwiriyajan S
    Eur J Clin Pharmacol; 2007 May; 63(5):451-6. PubMed ID: 17342480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
    Mugabo P; Els I; Smith J; Rabie H; Smith P; Mirochnick M; Steyn W; Hall D; Madsen R; Cotton MF
    S Afr Med J; 2011 Sep; 101(9):655-8. PubMed ID: 21920159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum.
    Usach I; Peris JE
    Int J Pharm; 2011 Oct; 419(1-2):186-91. PubMed ID: 21843608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.
    Andersen LP; Werner MU; Rosenkilde MM; Harpsøe NG; Fuglsang H; Rosenberg J; Gögenur I
    BMC Pharmacol Toxicol; 2016 Feb; 17():8. PubMed ID: 26893170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding of nevirapine extended release tablet remnants in stools does not threaten the success of combination antiretroviral therapy.
    Stephan C; León W
    HIV Med; 2014 Feb; 15(2):124-8. PubMed ID: 24112515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
    Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
    Sun H; Ting L; Machineni S; Praestgaard J; Kuemmell A; Stein DS; Sunkara G; Kovacs SJ; Villano S; Tanaka SK
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7431-7435. PubMed ID: 27736760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.